A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...

Speaking in Auckland this morning, Prime Minister Christopher Luxon said the New Zealand Institute for Advanced Technology ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Biocon aims to introduce generic versions of the obesity drug Wegovy in India and Canada by late 2026 or early 2027, ...

Biocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027.

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...